Log in

Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Repeat liver resection (RLR) for recurrent HCC (rHCC) is a widely accepted treatment modality. However, early recurrence rate is high, frequently resulting in futile resection. We performed this study to evaluate preoperative factors, including the value of inflammatory indices, in predicting early (<1 year) recurrence in patients who underwent RLR for rHCC. This may help clinicians better select patients for RLR, while excluding cases in which RLR for rHCC would likely be futile.

Methods

This is a retrospective study of 80 patients where 90 operative cases of RLR and 84 cases of early recurrence (<1 year) post-RLR were evaluated. Preoperative predictors of early recurrence and overall survival (OS) were assessed.

Results

There were 31 (34.4%) early recurrences with a 5-year OS of 38.9%. Elevated platelet-to-lymphocyte ratio (PLR) >103.6 was a significant independent preoperative predictor of both early recurrence, relative risk (RR) 4.284 (P = 0.001) and OS, RR 2.139 (P = 0.027), while alphafetoprotein (AFP) ≥ 200 was a significant independent preoperative predictor of early recurrence only, RR 11.655 (P = 0.030). Patients were followed-up at a median of 14.3 months with 54.8% develo** intrahepatic recurrences and 19.4% develo** extrahepatic recurrences.

Conclusion

Both, elevated PLR and AFP ≥ 200 were independent predictors of early (<1 year) recurrence after RLR for rHCC, while only an elevated PLR was an independent preoperative prognosticators of overall survival. Indication for RLR should be carefully discussed in patients with relapsed HCC with an elevated PLR, due to the potential of early recurrence and poor overall survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Poon RT, Fan ST, Lo CM, Liu CL, Wong J (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235(3):373

    Article  Google Scholar 

  2. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38(2):200–207

    Article  Google Scholar 

  3. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214(2):114

    Article  CAS  Google Scholar 

  4. Wu JC, Huang YH, Chau GY, Su CW, Lai CR, Lee PC et al (2009) Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 51(5):890–897

    Article  Google Scholar 

  5. Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JP et al (2008) Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 32(8):1757–1762. https://doi.org/10.1007/s00268-008-9552-6

    Article  CAS  PubMed  Google Scholar 

  6. Mano Y, Shirabe K, Yamashita YI, Harimoto N, Tsujita E, Takeishi K et al (2013) Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg 258(2):301–305

    Article  Google Scholar 

  7. Goh BK, Kam JH, Lee SY, Chan CY, Allen JC, Jeyaraj P et al (2016) Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥ 10 cm) hepatocellular carcinoma. J Surg Oncol 113(6):621–627

    Article  CAS  Google Scholar 

  8. Chan AW, Chan SL, Wong GL, Wong VW, Chong CC, Lai PB et al (2015) Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol 22(13):4138–3148

    Article  Google Scholar 

  9. Yang HJ, Jiang JH, Liu QA, Zhou CM, Du YF, Wu T et al (2017) Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection. Tumor Biol 39(6):1–8. https://doi.org/10.1177/1010428317707375

    Article  CAS  Google Scholar 

  10. Bismuth H (1982) Surgical anatomy and anatomical surgery of the liver. World J Surg 6(1):3–9. https://doi.org/10.1007/BF01656368

    Article  CAS  PubMed  Google Scholar 

  11. Guo YX, Tan EK, Krishnamoorthy TL, Tan CK, Tan BH, Tan TT, et al (2019) Outcome of salvage liver transplant for recurrent hepatocellular carcinoma: a comparison with primary liver transplant. Ann Hepato Biliary Pancreat Surg 23(1):1–7

  12. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P et al (2003) Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 9(5):513–520

    Article  Google Scholar 

  13. Lee KK, Kim DG, Moon IS, Lee MD, Park JH (2010) Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol 101(1):47–53

    Article  Google Scholar 

  14. Goh BK, Teo JY, Chan CY, Lee SY, Cheow PC, Chung AY (2017) Laparoscopic repeat liver resection for recurrent hepatocellular carcinoma. ANZ J Surg 87(10):143–146

    Article  Google Scholar 

  15. Minagawa M, Makuuchi M, Takayama T, Kokudo N (2003) Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238(5):703–710

    Article  Google Scholar 

  16. Itamoto T, Nakahara H, Amano H, Kohashi T, Ohdan H, Tashiro H et al (2007) Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 141(5):589–597

    Article  Google Scholar 

  17. Goh BK, Syn N, Teo JY, Guo YX, Lee SY, Cheow PC et al (2018) Perioperative outcomes of laparoscopic repeat liver resection for recurrent HCC: comparison with open repeat liver resection for recurrent HCC and laparoscopic resection for primary HCC. World J Surg 43:1–8. https://doi.org/10.1007/s00268-018-4828-y

    Article  Google Scholar 

  18. Pang RW, Joh JW, Johnson PJ, Monden M, Pawlik TM, Poon RT (2008) Biology of hepatocellular carcinoma. Ann Surg Oncol 15(4):962–971

    Article  Google Scholar 

  19. Yamamoto K, Imamura H, Matsuyama Y, Kume Y, Ikeda H, Norman GL et al (2010) AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC. J Gastroenterol 45(12):1272–1282

    Article  CAS  Google Scholar 

  20. Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P et al (2001) Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 34(4):570–575

    Article  CAS  Google Scholar 

  21. Huang ZY, Liang BY, **ong M, Zhan DQ, Wei S, Wang GP et al (2012) Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Ann Surg Oncol 19(8):2515–2525

    Article  Google Scholar 

  22. Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K et al (1998) Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 227(1):80

    Article  CAS  Google Scholar 

  23. Zhou Y, Sui C, Li B, Yin Z, Tan Y, Yang J et al (2010) Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol 8(1):55

    Article  Google Scholar 

  24. Honn KV, Tang DG, Crissman JD (1992) Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev 11(3):325–351

    Article  CAS  Google Scholar 

  25. Balkwill F, Mantovani A (2001) Inflammation and cancer: Back to Virchow? Lancet 357(9255):539–545

    Article  CAS  Google Scholar 

  26. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860

    Article  CAS  Google Scholar 

  27. Zhao Y, Si G, Zhu F, Hui J, Cai S, Huang C et al (2017) Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 8(14):22854

    PubMed  PubMed Central  Google Scholar 

  28. Li X, Chen ZH, **ng YF, Wang TT, Wu DH, Wen JY et al (2015) Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumor Biol 36(4):2263–2269

    Article  Google Scholar 

  29. Fan W, Zhang Y, Wang Y, Yao X, Yang J, Li J (2015) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization. PLoS ONE 10(3):1–14

    Google Scholar 

  30. Liao W, Zhang J, Zhu Q, Qin L, Yao W, Lei B et al (2014) Preoperative neutrophil-to-lymphocyte ratio as a new prognostic marker in hepatocellular carcinoma after curative resection. Transl Oncol 7(2):248–255

    Article  Google Scholar 

  31. Ji F, Liang Y, Fu SJ, Guo ZY, Shu M, Shen SL et al (2016) A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI). BMC Cancer 16(1):137

    Article  Google Scholar 

  32. Yamamura K, Sugimoto H, Kanda M, Yamada S, Nomoto S, Nakayama G et al (2014) Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection. J Hepato Biliary Pancreat Sci 21(9):682–688

    Article  Google Scholar 

  33. Zhu WJ, Huang CY, Li C, Peng W, Wen TF, Yan LN et al (2013) Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting Milan criteria after curative resection. Asian Pac J Cancer Prev 14(12):7101–7106

    Article  Google Scholar 

  34. Ni XC, Yi Y, Fu YP, He HW, Cai XY, Wang JX, et al (2015) Prognostic value of the modified Glasgow prognostic score in patients undergoing radical surgery for hepatocellular carcinoma. Medicine 94(36):1–8

    Article  Google Scholar 

  35. Okamura Y, Ashida R, Ito T, Sugiura T, Mori K, Uesaka K (2015) Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma. World J Surg 39(6):1501–1509. https://doi.org/10.1007/s00268-015-2982-z

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brian K. P. Goh.

Ethics declarations

Conflict of interest

All authors have no conflict of interest and declarations

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, Y., Chua, D.W., Koh, YX. et al. Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma. World J Surg 43, 2587–2594 (2019). https://doi.org/10.1007/s00268-019-05051-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-019-05051-6

Navigation